Barriers to and Facilitators for Accessing HPV Vaccination in Migrant and Refugee Populations: A Systematic Review

Author:

Graci Davide1ORCID,Piazza Nicolò1,Ardagna Salvatore1,Casuccio Alessandra1ORCID,Drobov Anton2ORCID,Geraci Federica1,Immordino Angelo3ORCID,Pirrello Alessandra1,Restivo Vincenzo4ORCID,Rumbo Riccardo1,Stefano Rosalba1,Virone Roberta1,Zarcone Elena1,Immordino Palmira15ORCID

Affiliation:

1. Department of Health Promotion, Mother and Childcare, Internal Medicine and Medical Specialties “G. D’Alessandro”, University of Palermo, Via del Vespro 133, 90127 Palermo, Italy

2. Department of Public Health, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic

3. Department of Biomedicine, Neuroscience and Advanced Diagnostics, AOUP Paolo Giaccone, University of Palermo, Via del Vespro 133, 90127 Palermo, Italy

4. School of Medicine, University Kore of Enna, 94100 Enna, Italy

5. Centro di Ateneo “MIGRARE”, Università degli Studi di Palermo, 90133 Palermo, Italy

Abstract

Human papillomavirus (HPV) is the most prevalent sexually transmitted virus globally and a primary cause of cervical cancer, which ranks fourth among tumors in both incidence and mortality. Despite the availability of effective vaccines worldwide, HPV vaccination rates vary, especially among migrant and refugee populations. Indeed, migrant status may act as a determinant against accessing vaccinations, among many other factors. The objective of this paper is to evaluate barriers to and facilitators for accessing HPV vaccination in migrant and refugee populations. A systematic review of the existing peer-reviewed academic literature was conducted according to the PRISMA 2020 guidelines in which we examined thirty-four studies to evaluate HPV vaccination rates in these populations and identify factors acting as barriers or facilitators. Key determinants include socio-economic status and health literacy. Communication barriers, including language and cultural factors, also impact access to information and trust in the health workforce. Understanding and considering these factors is crucial for developing proper and inclusive vaccination strategies to ensure that no population is overlooked.

Publisher

MDPI AG

Reference57 articles.

1. European Centre for Disease Prevention and Control (2020). Guidance on HPV Vaccination in EU Countries: Focus on Boys, People Liv-ing with HIV and 9 Valent HPV Vaccine Introduction, Publications Office. Available online: https://data.europa.eu/doi/10.2900/71487.

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA A Cancer J. Clin.,2021

3. Human Papillomavirus (HPV) and cervical cancer;Wardak;Med. Dosw. Mikrobiol.,2016

4. Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence;Yang;Am. J. Clin. Oncol.,2018

5. Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15–29 Years in the United States, 1999–2017: An Ecologic Study;Mix;Cancer Epidemiol. Biomark. Prev.,2021

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3